148 related articles for article (PubMed ID: 37104886)
1. Characteristic and management motor neuron disease in the largest tertiary hospital in the Philippines: A one-year period cross sectional analytic study.
Prado MB; Hamoy-Jimenez G; Adiao KJ
J Clin Neurosci; 2023 Jun; 112():68-72. PubMed ID: 37104886
[TBL] [Abstract][Full Text] [Related]
2. Nutritional support teams increase percutaneous endoscopic gastrostomy uptake in motor neuron disease.
Zhang L; Sanders L; Fraser RJ
World J Gastroenterol; 2012 Nov; 18(44):6461-7; discussion p.6466. PubMed ID: 23197892
[TBL] [Abstract][Full Text] [Related]
3. Estimating Amyotrophic Lateral Sclerosis and Motor Neuron Disease Prevalence in Portugal Using a Pharmaco-Epidemiological Approach and a Bayesian Multiparameter Evidence Synthesis Model.
Conde B; Winck JC; Azevedo LF
Neuroepidemiology; 2019; 53(1-2):73-83. PubMed ID: 31117082
[TBL] [Abstract][Full Text] [Related]
4. Epidemiological characteristics of motor neuron disease in Chinese patients.
Cui F; Liu M; Chen Y; Huang X; Cui L; Fan D; Pu C; Lu J; Zhou D; Zhang C; Yan C; Li C; Ding X; Liu Y; Li X; Jiang Y; Zhang J; Shang H; Yao X; Ding Y; Niu Q; Wang L
Acta Neurol Scand; 2014 Aug; 130(2):111-7. PubMed ID: 24689740
[TBL] [Abstract][Full Text] [Related]
5. Motor neuron disease in black African patients at a tertiary care hospital in Soweto, South Africa.
Floudiotis N; Modi G; Mochan A
J Neurol Sci; 2023 Aug; 451():120710. PubMed ID: 37379726
[TBL] [Abstract][Full Text] [Related]
6. Cell-based therapies for amyotrophic lateral sclerosis/motor neuron disease.
Abdul Wahid SF; Law ZK; Ismail NA; Lai NM
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011742. PubMed ID: 31853962
[TBL] [Abstract][Full Text] [Related]
7. Demographics and clinical characteristics of primary lateral sclerosis: case series and a review of literature.
Ramanathan RS; Rana S
Neurodegener Dis Manag; 2018 Feb; 8(1):17-23. PubMed ID: 29316850
[TBL] [Abstract][Full Text] [Related]
8. Atypical motor neuron disease and related motor syndromes.
Verma A; Bradley WG
Semin Neurol; 2001 Jun; 21(2):177-87. PubMed ID: 11442326
[TBL] [Abstract][Full Text] [Related]
9. Identification and outcomes of clinical phenotypes in amyotrophic lateral sclerosis/motor neuron disease: Australian National Motor Neuron Disease observational cohort.
Talman P; Duong T; Vucic S; Mathers S; Venkatesh S; Henderson R; Rowe D; Schultz D; Edis R; Needham M; Macdonnell R; McCombe P; Birks C; Kiernan M
BMJ Open; 2016 Sep; 6(9):e012054. PubMed ID: 27694488
[TBL] [Abstract][Full Text] [Related]
10. TDP-43 in differential diagnosis of motor neuron disorders.
Dickson DW; Josephs KA; Amador-Ortiz C
Acta Neuropathol; 2007 Jul; 114(1):71-9. PubMed ID: 17569066
[TBL] [Abstract][Full Text] [Related]
11. The Swedish motor neuron disease quality registry.
Longinetti E; Regodón Wallin A; Samuelsson K; Press R; Zachau A; Ronnevi LO; Kierkegaard M; Andersen PM; Hillert J; Fang F; Ingre C
Amyotroph Lateral Scler Frontotemporal Degener; 2018 Nov; 19(7-8):528-537. PubMed ID: 30296856
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for respiratory failure of motor neuron disease in a multiracial Asian population.
Deng X; Hao Y; Xiao B; Tan EK; Lo YL
J Clin Neurosci; 2017 May; 39():137-141. PubMed ID: 28089419
[TBL] [Abstract][Full Text] [Related]
13. Identifying who will benefit from non-invasive ventilation in amyotrophic lateral sclerosis/motor neurone disease in a clinical cohort.
Berlowitz DJ; Howard ME; Fiore JF; Vander Hoorn S; O'Donoghue FJ; Westlake J; Smith A; Beer F; Mathers S; Talman P
J Neurol Neurosurg Psychiatry; 2016 Mar; 87(3):280-6. PubMed ID: 25857659
[TBL] [Abstract][Full Text] [Related]
14. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
Miller RG; Mitchell JD; Lyon M; Moore DH
Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and factors associated with advanced care directives in a motor neuron disease multidisciplinary clinic in Australia.
Phua CS; Ng A; Brooks C; Harrington Z; Vedam H; Huynh T; Seccombe D; Aouad P; Cordato D
Postgrad Med J; 2021 Sep; 97(1151):566-570. PubMed ID: 32788311
[TBL] [Abstract][Full Text] [Related]
16. Motor neurone disease: a practical update on diagnosis and management.
Wood-Allum C; Shaw PJ
Clin Med (Lond); 2010 Jun; 10(3):252-8. PubMed ID: 20726457
[TBL] [Abstract][Full Text] [Related]
17. Medical technology assessment. Electrodiagnosis in motor neuron diseases and amyotrophic lateral sclerosis.
de Carvalho M; Johnsen B; Fuglsang-Frederiksen A
Neurophysiol Clin; 2001 Oct; 31(5):341-8. PubMed ID: 11817274
[TBL] [Abstract][Full Text] [Related]
18. Motor neuron disease in patients with HIV infection: Report of two cases and brief review of the literature.
Lorenzoni PJ; Ducci RD; Dalledone GO; Kay CSK; de Almeida SM; Werneck LC; Scola RH
Clin Neurol Neurosurg; 2018 Aug; 171():139-142. PubMed ID: 29909186
[TBL] [Abstract][Full Text] [Related]
19. Distinct Clinical Features and Outcomes in Motor Neuron Disease Associated with Behavioural Variant Frontotemporal Dementia.
Cortés-Vicente E; Turon-Sans J; Gelpi E; Clarimón J; Borrego-Écija S; Dols-Icardo O; Illán-Gala I; Lleó A; Illa I; Blesa R; Al-Chalabi A; Rojas-García R
Dement Geriatr Cogn Disord; 2018; 45(3-4):220-231. PubMed ID: 29886477
[TBL] [Abstract][Full Text] [Related]
20. Assessing the upper motor neuron in amyotrophic lateral sclerosis using the triple stimulation technique: A multicenter prospective study.
Grapperon AM; Verschueren A; Jouve E; Morizot-Koutlidis R; Lenglet T; Pradat PF; Salachas F; Bernard E; Delstanche S; Maertens de Noordhout A; Guy N; Danel V; Delval A; Delmont E; Rolland AS; Pulse Study Group ; Jomir L; Devos D; Wang F; Attarian S
Clin Neurophysiol; 2021 Oct; 132(10):2551-2557. PubMed ID: 34455313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
